Eli Lilly And Co
General ticker "LLY" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $711.3B
Eli Lilly And Co follows the US Stock Market performance with the rate: 52.0%.
Estimated limits based on current volatility of 1.8%: low 757.97$, high 785.51$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends: last record date 2024-11-15, amount 1.30$ (Y0.68%)
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [477.59$, 729.03$]
- 2024-12-30 to 2025-12-30 estimated range: [460.48$, 716.57$]
Short-term LLY quotes
Long-term LLY plot with estimates
Financial data
| YTD | 2023-12-31 |
|---|---|
| Operating Revenue | $34,124.10MM |
| Operating Expenses | $23,798.70MM |
| Operating Income | $10,325.40MM |
| Non-Operating Income | $-3,770.80MM |
| Interest Expense | $485.90MM |
| R&D Expense | $9,313.40MM |
| Income(Loss) | $6,554.60MM |
| Taxes | $1,314.20MM |
| Profit(Loss) | $5,240.40MM |
| Stockholders Equity | $10,771.90MM |
| Inventory | $5,772.80MM |
| Assets | $64,006.30MM |
| Operating Cash Flow | $4,240.10MM |
| Capital expenditure | $7,392.10MM |
| Investing Cash Flow | $-7,152.70MM |
| Financing Cash Flow | $3,495.60MM |
| Earnings Per Share* | $5.80 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.